Stocktoria
LivaNova PLC LIVN
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2015-10-19
LivaNova PLC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 67.7% | 68.1% | 65.5% | 69.2% | 68.2% |
| Operating margin | 14.4% | 10.3% | -5.9% | -7.5% | -0.1% |
| Net margin | -17.5% | 5.0% | 1.5% | -8.4% | -13.1% |
| FCF margin | 12.5% | 10.8% | 3.5% | 4.2% | 7.4% |
| Return on assets | -9.3% | 2.5% | 0.7% | -3.8% | -6.2% |
| Return on equity | -20.2% | 4.8% | 1.4% | -7.1% | -10.5% |
| Debt / equity | 0.31× | 0.47× | 0.46× | 0.45× | 0.18× |
| Current ratio | 1.36 | 2.87 | 2.95 | 2.98 | 0.97 |
| Revenue growth | 10.7% | 8.7% | 12.9% | -1.3% | 10.8% |
Source: SEC EDGAR filings · CIK 0001639691 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.